The Italian Sunshine Act (Law No. 62/2022) mandates pharmaceutical, medical device, and other healthcare-related companies to publicly disclose financial relationships with healthcare professionals (HCPs) and healthcare organizations (HCOs). This initiative aims to enhance transparency and prevent corruption within the healthcare sector.